Ayele, Wondimu, Habtamu Tesfaye, Roman Gebreyes, and Tesfayi Gebreselassie
1
Aziz, A.
1
Åsa Hammar and Guro Årdal
1
B. A. McCormick and R. J. Eltringham
1
B. Akkazieva
1
B. Birmaher
1
B. Brown
1
B. C. Zanoni
1
B. Chimukangara
1
B. Davis
1
B. Duthey, Ph.D
1
B. Frank‐Hatitchki: O. Ogunwobi
1
B. Hauer, R. Loddenkemper, A. Detjen, et al.
1
B. Herstad
1
B. J. Mohapia
1
B. James, Ph.D.
1
B. Kollo
1
B. Lee, E. Pearce, D. Buscher
1
B. M. McCoy
1
B. Moges, B. Amare, F. Asfaw, et al.
1
B. Noubary
1
B. Nurcombe
1
B. Ohye
1
B. O’Donnell
1
B. Poelman, K.G. Dewey, et al.
1
B. Pozzoni
1
B. Rajamaki
1
B. Refetllari
1
B. Russell et al.
1
B. S. Singhal
1
B. StamblerI
1
B. Subha Sri
1
B. Tesfaye
1
B. Unnikrishnan
1
B. Vitiello
1
B. Weil
1
B. Williams
1
B. Wolff, L. de Carlo
1
B. Xhani
1
B.Bandelo, S. Michaelis, D. Wedekind
1
B.Callender, V. Adams, et al.
1
Ba, M.
1
Baas, Stephan
1
Back Pack Health Worker Team (BPHWT)
1
Baer B.
1
BafF e.V.
1
Baghdadi-Sabeti , G.
1
Bakare, M.O., Ubochi, V.N., Ebigbo, P.O. and Orovwigho, A.O.
1
Balaji, V., P. Rupali, K. Walia, et al.
1
Balamurali, M.
1
Baldacchino, D.
1
Ballot, Andreas
1
Balma, L.
1
Bambrick, H.
1
BAMF
1
Banda, P
1
Banerjee, A.
1
Bangladesh Bureau of Statistics (BBS) and UNICEF Bangladesh
1
Bangladesh Institute of Development Studies (BIDS) Grantee
1
Bangladesh Nursing Council
1
Bangladesh Red Crescent Society , German Red Cross
1
Bangladesh, Ministry of Disaster Management and Relief (MoDMR)
1
Bangpan, M
1
Banks, L.M. & Keogh, M.
1
Baraldi, E.
1
Barbara Jones, Dr. Jaime Benavente, Dr. Moussa Coulibaly
1
Barbara Kühlen
1
Barbara McPake, Ijeoma Edoka, Sophie Witter, et al.
1
Barben et al.
1
BardenO'Fallon J, Barry MA, Brodish P, et al.
1
Barker, G.
1
Barnes, H.
1
Barráez, D.
1
Barry A, Barden O’Fallon J, Hazerjian J, Brodish P
1
Bartlett, E. S.
1
Bartoloni, A.
1
Basic Needs Basic Rights
1
Basinga, P., Gertler, P.J., Binagwaho, A., et al.
1
Bastable, Andy and Russell, Lucy
1
Bateman, E. D.
1
Bateman, E.D.
1
Batista, C.
1
Bay, N. et al.
1
Bayadinova, J.A., Sardo, Higgins-Nogareda, V., Scott, J. & MacKinnon, B.
1
Bayão T.S., Cupertino M.C., Gomes A.P. et al
1
Baylor College of Medicine Children’s Foundation Malawi
1
Baylor Tingathe Community Outreach Programme
1
Bazargani, Y.T.
1
BBC Media Action
1
Beard, R. Suzanne
1
Beardsley, Kip., A. Zapfel, and T. Williamson
1
Beattie, T. K.
1
Becker, A.
1
Beckman, M.
1
Bedding, E.J.
1
Begum, T. S. M.
1
Belkum, A.van, T. T. Bachmann, G. Lüdke, et al.
1
Bendavid E. et al.
1
Benitez J.C., Mansour M., Pecho M., et al.
1
Benjamin O Alli [et al.]
1
Benson-Martin, J.
1
Berkley, James A.
1
Berkowitz, A.L.
1
Berlin, E.
1
Bernadette Daelmans, Olufemi Oladapo, Özge Tuncalp et al
1
Bernal, O.
1
Bernal, OA
1
Bernard M. Branson, S. Michele Owen, Laura G. Wesolowski et
1
Bernd Rechel
1
Bernhard-Nocht-Institut für Tropenmedizin (BNIT)
1
Berry, P.
1
Betrò, S.
1
Bettina B., J. Barnes, A. Carmona
1
Beverly D Glass
1
Beyond Blue
1
Béatrice Boyer
1
Bhatnagar, A.
1
Bhopal,S., and M. Nielsen
1
Bhuiyan MR , et al.
1
Bhutta, Zulfiqar et al.
1
Bickley, Shaun
1
Biddle, L.
1
Biedron, C.
1
Bigna J. J., M.A. Amougou
1
Bigoni, A.
1
Bill & Melinda Gates Foundation
1
Bill & Melinda Gates Foundation, et al.
1
Bill & Melinda Gates Foundation, World Health Organization, Centers for Disease Control and Prevention, UN Children's Fund, Government of the Central African Republic
1
Bio Med Central
1
Bioforce Development Institute – Burkina Faso Country Survey
1
Bioline international
1
BioMed Research International
1
BioNTech
1
Birkeland,N.M.
1
Bischöfliches Hilfswerk MISEREOR, Brot für die Welt, Global Policy Forum
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.more
Le Bénin est un pays à épidémie mixte car il existe des poches de concentration de fortes prévalences
au sein de certaines populations clés plus exposées aux risques d’infection, notamment les TS et
leurs partenaires, les prisonniers, les HSH et les UDI. Les sections suivantes présentero...nt la
prévalence dans les différents groupes.
more
Promotion of the quality of clinical care through the identification, promotion and standardization of appropriate procedures, equipment and materials, particularly at district hospital level.
The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise of public health and provides a framework to inform the exercise of the new essential functions. The th...ird section proposes a new integrated approach for implementing the EPHFs. The fourth section presents a new list of 11 EPHFs related to each stage of this integrated approach. Finally, in the last section, considerations are put forth to guide EPHF implementation as a means of strengthening the health sector.more
Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition: web annex A: protocol for evaluating minimum package of care of morbidity management and disability prevention for lymphoedema management in designated health facilit...ies.more
A lack of knowledge about the threat of vaccine-preventable diseases, risks and benefits of vaccines, mistrust of government and health workers, poor service delivery and alternative health or religious beliefs play a role in lower uptake of some vaccines. These challenges underscore the importance ...of early integration and investment in a thoughtful communication plan for immunization programmes. This World Health Organization (WHO) report presents communication guidance and specific considerations for countries that plan to introduce human papillomavirus (HPV) vaccine into their national immunisation programme as part of an effort to prevent cervical cancer.more
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...te lymphatic filariasis as a public health problem. This study aims to produce the first geospatial estimates of the global prevalence of lymphatic filariasis infection over time, to quantify progress towards elimination, and to identify geographical variation in distribution of infection.more
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol...icy-makers and other stakeholders to strengthen their response to the dementia challenge.
Executive Summary available in Arabic, Chinese, French, Russian and Spanish at: https://www.who.int/mental_health/neurology/dementia/guidelines_risk_reduction/en/ more
The Government of Malawi, in fulfilling its primary role of protecting the lives of its vulnerable citizens during disasters and reducing their exposure to risk through preparedness, led the development of a National Coronavirus Disease (COVID-19) Preparedness and Response Plan.
This factsheet describes the work and activities of the Center for Disease Control and Prevention (CDC) in Mozambique as well as its impact in this country.
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.